Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

GenoPlex licenses rights to AD discoveries from MGH

March 5, 1999

Single-isomer version of epilepsy Rx developed at ABS

March 5, 1999

Lilly delays phase III clinical trials of migraine compound

March 5, 1999

New Astra compounds for the therapy of 5-HT-mediated disorders

March 5, 1999

Medtronic and Cognetix to develop new treatment for epilepsy

March 5, 1999

Wyeth-Ayerst and Neurocrine to develop drugs targeting neurotransmitter transporters

March 5, 1999

FDA ruling upholds orphan drug exclusivity for Avonex

March 5, 1999

NMDA receptor antagonists potentiate opioid-induced analgesia in animals

March 4, 1999

Second-generation tetracyclines afford significant neuroprotection in stroke model

March 4, 1999

Dual 5-HT reuptake inhibitors/5-HT1A antagonists patented by Lundbeck

March 4, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...